What changed in this filing

/stocks — the workspaceLOADING

Item 5. Market for Registrant’s Common Equity

2023-05-25 compared with 2022-05-26 · 21 added, 61 removed, 14 unchanged (85% of the section changed)

5 unchanged sentences

We did not pay any cash dividends on our common stock during the fiscal years ended March 31, 2023, and 2022.

Holders of our common stock are entitled to dividends if and when declared by our Board of Directors

(“Board”), out of funds legally available.

Generally, we have retained our earnings for use in the business.

We currently intend to retain future earnings to fund ongoing operations and finance the growth and development of our business.

future determination concerning the payment of dividends will depend upon our financial condition, results of operations, capital requirements and any other factors deemed relevant by our Board.

Holders of our common stock are entitled to dividends if and when declared by our Board of

Directors (“Board”), out of funds legally available.

Generally, we have retained our earnings for use in the business and to repurchase our common stock.

We currently intend to retain future earnings to fund ongoing operations, finance

the growth and development of our business and continue to repurchase our common stock.

Any future determination concerning the payment of dividends will depend upon our financial condition, results of operations, capital requirements

and any other factors deemed relevant by our Board.

PURCHASES OF OUR COMMON STOCK

The following table provides information regarding our total purchases of 283,420 shares of e Plus inc.

common stock during the fiscal year ended March 31, 2022, including a total of 227,990 shares

purchased as part of the publicly announced share repurchase plans or programs.

The numbers of shares and price per share for the prior periods presented in the table have been retroactively adjusted to reflect the stock split.

See Note 1 “Organization and Summary of Significant Accounting Policies ” and Note 11 “Stockholders’ Equity” in the consolidated financial statements included elsewhere in this

report for additional information on the stock split.

The following table provides information regarding our purchases of our common stock during the three months ended March 31, 2023.

Please refer to Note 12 , “Stockholders’ Equity” in the Notes to the Consolidated Financial Statements included in Part II, Item 8 of this Annual Report on Form 10-K for additional

number of shares purchased (1)

price paid per share

Total number of

1 unchanged sentence

as part of publicly

announced plans

Maximum number (or

approximate dollar

value) of shares that

may yet be purchased

announced plans or

Maximum number

of shares that may

yet be purchased

under the plans or

April 1, 2021 through April 30, 2021

May 1, 2021 through May 27, 2021

May 28, 2021 through May 31, 2021

June 1, 2021 through June 30, 2021

July 1, 2021 through July 31, 2021

August 1, 2021 through August 31, 2021

September 1, 2021 through September 30, 2021

October 1, 2021 through October 31, 2021

November 1, 2021 through November 30, 2021

December 1, 2021 through December 31, 2021

January 1, 2023 through January 31, 2023

1 unchanged sentence

March 1, 2023 through March 31, 2023

All shares acquired were in open-market purchases, except for 55,430 shares, out of which 1,998 were repurchased in May 2021 and 53,432 in June 2021 to satisfy tax withholding obligations that arose due

to the vesting of shares of restricted stock.

The share purchase authorization in place for the month ended April 30, 2021, had purchase limitations on the number of shares of up to 1,000,000 shares.

As of April 30, 2021, the remaining authorized shares to be purchased were

As of May 27, 2021, the authorization under the then-existing share repurchase plan expired.

On March 18, 2021, the board of directors authorized the company to repurchase up to 1,000,000 shares of our outstanding common stock commencing on May 28, 2021 and continuing to May 27, 2022.

As of May 31, 2021, the remaining

authorized shares to be purchased were 1,000,000.

The share purchase authorization in place for the month ended June 30, 2021, had purchase limitations on the number of shares of up to 1,000,000 shares.

As of June 30, 2021, the remaining authorized shares to be purchased were

The share purchase authorization in place for the month ended July 31, 2021, had purchase limitations on the number of shares of up to 1,000,000 shares.

As of July 31, 2021, the remaining authorized shares to be purchased were

The share purchase authorization in place for the month ended August 31, 2021, had purchase limitations on the number of shares of up to 1,000,000 shares.

As of August 31, 2021, the remaining authorized shares to be purchased were

The share purchase authorization in place for the month ended September 30, 2021, had purchase limitations on the number of shares of up to 1,000,000 shares.

As of September 30, 2021, the remaining authorized shares to be purchased

were 901,944.

The share purchase authorization in place for the month ended October 31, 2021, had purchase limitations on the number of shares of up to 1,000,000 shares.

As of October 31, 2021, the remaining authorized shares to be purchased

were 901,944.

The share purchase authorization in place for the month ended November 30, 2021, had purchase limitations on the number of shares of up to 1,000,000 shares.

As of November 30, 2021, the remaining authorized shares to be purchased

were 901,944.

The share purchase authorization in place for the month ended December 31, 2021, had purchase limitations on the number of shares of up to 1,000,000 shares.

As of December 31, 2021, the remaining authorized shares to be purchased

were 852,001.

The share purchase authorization in place for the month ended January 31, 2022, had purchase limitations on the number of shares of up to 1,000,000 shares.

As of January 31, 2022, the remaining authorized shares to be purchased

were 772,010.

The share purchase authorization in place for the month ended February 28, 2022, had purchase limitations on the number of shares of up to 1,000,000 shares.

As of February 28, 2022, the remaining authorized shares to be purchased

were 772,010.

The share purchase authorization in place for the month ended March 31, 2022, had purchase limitations on the number of shares of up to 1,000,000 shares.

As of March 31, 2022, the remaining authorized shares to be purchased were

The timing and expiration date of the share repurchase authorizations are included in Note 11 , “Stockholders’ Equity” to our consolidated financial statements included elsewhere in this report.

All shares were acquired in open-market purchases.

The amounts presented in this column are the remaining number of shares that may be repurchased after repurchases during the month.

On March 24, 2022, our board of directors authorized the repurchase of up to 1,000,000 shares

of our outstanding common stock, over a 12-month period beginning May 28, 2022.

On March 22, 2023, our board of directors authorized the repurchase of up to 1,000,000 shares of our outstanding

common stock, over a 12-month period beginning May 28, 2023.

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-K

Item 5. Market for Registrant’s Common Equity